These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 29269441)

  • 21. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
    Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
    PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
    Malvisi L; Taddei L; Yarraguntla A; Wilkinson TMA; Arora AK;
    Respir Res; 2021 Feb; 22(1):67. PubMed ID: 33627095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
    Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ;
    Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629
    [No Abstract]   [Full Text] [Related]  

  • 27. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
    Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection.
    Kayongo A; Bartolomaeus TUP; Birkner T; Markó L; Löber U; Kigozi E; Atugonza C; Munana R; Mawanda D; Sekibira R; Uwimaana E; Alupo P; Kalyesubula R; Knauf F; Siddharthan T; Bagaya BS; Kateete DP; Joloba ML; Sewankambo NK; Jjingo D; Kirenga B; Checkley W; Forslund SK
    Microbiol Spectr; 2023 Feb; 11(2):e0213921. PubMed ID: 36790203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum
    George LM; Haigh RD; Mistry V; Haldar K; Barer MR; Oggioni MR; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3663-3667. PubMed ID: 30510409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short term dynamics of the sputum microbiome among COPD patients.
    Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD
    PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
    Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
    J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease.
    Qi YJ; Sun XJ; Wang Z; Bin YF; Li YH; Zhong XN; Bai J; Deng JM; He ZY
    Chin Med J (Engl); 2020 Mar; 133(5):542-551. PubMed ID: 32053571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease.
    Meldrum OW; Donaldson GC; Narayana JK; Xaverius Ivan F; Jaggi TK; Mac Aogáin M; Finney LJ; Allinson JP; Wedzicha JA; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Aug; 210(3):298-310. PubMed ID: 38315959
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations.
    Mao X; Li Y; Shi P; Zhu Z; Sun J; Xue Y; Wan Z; Yang D; Ma T; Wang J; Zhu R
    Microb Pathog; 2023 Nov; 184():106335. PubMed ID: 37673353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
    Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lung microbiome and exacerbations of COPD.
    Dy R; Sethi S
    Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.